- Home
- PODD vs NTNX Comparison
PODD vs NTNX Comparison
Compare PODD & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- NTNX
- Stock Information
- Founded
- PODD 2000
- NTNX 2009
- Country
- PODD United States
- NTNX United States
- Employees
- PODD N/A
- NTNX N/A
- Industry
- PODD Medical/Dental Instruments
- NTNX Computer Software: Prepackaged Software
- Sector
- PODD Health Care
- NTNX Technology
- Exchange
- PODD Nasdaq
- NTNX Nasdaq
- Market Cap
- PODD 22.1B
- NTNX 20.5B
- IPO Year
- PODD 2007
- NTNX 2016
- Fundamental
- Price
- PODD $311.95
- NTNX $69.08
- Analyst Decision
- PODD Strong Buy
- NTNX Buy
- Analyst Count
- PODD 19
- NTNX 15
- Target Price
- PODD $338.79
- NTNX $88.07
- AVG Volume (30 Days)
- PODD 461.0K
- NTNX 2.5M
- Earning Date
- PODD 11-06-2025
- NTNX 11-25-2025
- Dividend Yield
- PODD N/A
- NTNX N/A
- EPS Growth
- PODD N/A
- NTNX N/A
- EPS
- PODD 3.32
- NTNX 0.65
- Revenue
- PODD $2,359,500,000.00
- NTNX $2,537,927,000.00
- Revenue This Year
- PODD $29.27
- NTNX $17.50
- Revenue Next Year
- PODD $18.30
- NTNX $14.32
- P/E Ratio
- PODD $95.15
- NTNX $104.62
- Revenue Growth
- PODD 26.00
- NTNX 18.11
- 52 Week Low
- PODD $227.03
- NTNX $54.66
- 52 Week High
- PODD $353.50
- NTNX $83.36
- Technical
- Relative Strength Index (RSI)
- PODD 41.83
- NTNX 44.59
- Support Level
- PODD $320.76
- NTNX $67.23
- Resistance Level
- PODD $326.81
- NTNX $70.89
- Average True Range (ATR)
- PODD 7.35
- NTNX 1.45
- MACD
- PODD -0.26
- NTNX 0.12
- Stochastic Oscillator
- PODD 1.89
- NTNX 64.22
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About NTNX Nutanix Inc.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.